Middle East & Africa Transplantation Market Size & Outlook
Middle East & Africa transplantation market, 2018-2030 (US$M)
Related Markets
MEA transplantation market highlights
- The MEA transplantation market generated a revenue of USD 804.9 million in 2023.
- The market is expected to grow at a CAGR of 9.6% from 2024 to 2030.
- In terms of segment, tissue products was the largest revenue generating product in 2023.
- Immunosuppressive Drugs is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, South Africa is expected to register the highest CAGR from 2024 to 2030.
MEA data book summary
| Market revenue in 2023 | USD 804.9 million |
| Market revenue in 2030 | USD 1,530.3 million |
| Growth rate | 9.6% (CAGR from 2023 to 2030) |
| Largest segment | Tissue products |
| Fastest growing segment | Immunosuppressive Drugs |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Immunosuppressive Drugs, Tissue Products, Preservation Solutions |
| Key market players worldwide | AbbVie Inc, Arthrex, Zimmer Biomet Holdings Inc, Medtronic PLC, Novartis AG ADR, Stryker Corp, BioLife Solutions Inc, Teva Pharmaceutical Industries Ltd, Asahi Kasei Corp |
Other key industry trends
- In terms of revenue, MEA region accounted for 4.9% of the global transplantation market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 6,930.6 million by 2030.
Key Regions: U.S. , UK , Japan , Brazil , South Africa
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Transplantation Market Scope
Transplantation Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Middle East & Africa transplantation market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to transplantation market will help companies and investors design strategic landscapes.
Tissue products was the largest segment with a revenue share of 57.67% in 2023. Horizon Databook has segmented the Middle East & Africa transplantation market based on immunosuppressive drugs, tissue products, preservation solutions covering the revenue growth of each sub-segment from 2018 to 2030.
The MEA region consists of countries like South Africa, Saudi Arabia, and rest of the countries in MEA. This region consists of countries that are economically developed and thus a large number of surgical procedures are reported in the region. Saudi Arabia Center for Organ Transplantation has performed a large number of organ transplants and donations in the country.
This obstructs the growth of transplantation market in the country. According to NCBI, majority of the individuals are less willing to donate organs unless they are donating them to their close relatives. Thus, the growth of the market is comparatively slow in the region; however, there are various nonprofit organizations like the Organ Donor Foundation that help raise awareness and facilitate organ donations in the country.
Reasons to subscribe to Middle East & Africa transplantation market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Middle East & Africa transplantation market databook
-
Our clientele includes a mix of transplantation market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa transplantation market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa transplantation market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
MEA transplantation market size, by country, 2018-2030 (US$M)
Middle East & Africa Transplantation Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
